J. Raemaekers

发表

Itraconazole and multidrug resistance: Possible effects on remission rate and disease-free survival in acute leukemia

G. Vreugdenhil, J. Raemaekers, B. J. V. Dijke, 1993, Annals of Hematology.

Phase-II trial with M-CAVe-CEC as a salvage chemotherapeutic regimen for early relapsed or primary refractory Hodgkin's disease

M. Jongen‐Lavrencic, G. Vreugdenhil, J. Raemaekers, 1994, Annals of Hematology.

Early response to chemotherapy: a surrogate for final outcome of Hodgkin's disease patients that should influence initial treatment length and intensity?

V. Diehl, J. Raemaekers, J. Franklin, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

Comparison of Three Radiation Dose Levels after EBVP Regimen in Favorable Supradiaphragmatic Clinical Stages (CS) I-II Hodgkin’s Lymphoma (HL): Preliminary Results of the EORTC-GELA H9-F Trial.

C. Sebban, M. Henry-Amar, E. Noordijk, 2005 .

The achievements of the EORTC Lymphoma Group. European Organisation for Research and Treatment of Cancer.

M. Glabbeke, H. Kluin-Nelemans, M. Henry-Amar, 2002, European journal of cancer.

The role of rituximab in a case of EBV-related lymphoproliferative disease presenting with haemophagocytosis.

J. Raemaekers, P. Pickkers, K. Hebeda, 2009, The Netherlands journal of medicine.

Clostridium septicum sepsis and neutropenic enterocolitis in a patient treated with intensive chemotherapy for acute myeloid leukemia

B. D. de Pauw, J. Donnelly, P. Verweij, 1997, Annals of Hematology.

Allogeneic bone marrow transplantation for leukemia with marrow grafts depleted of lymphocytes by counterflow centrifugation.

J. Raemaekers, F. Preijers, J. Boezeman, 1990, Blood.

Efficacy of itraconazole in the prevention of fungal infections among neutropenic patients with hematologic malignancies and intensive chemotherapy. A double blind, placebo controlled study.

J. Raemaekers, I. Nováková, B. D. de Pauw, 1993, Leukemia & lymphoma.

Control of nausea and vomiting with ondansetron in patients treated with intensive non-cisplatin chemotherapy for acute myeloid leukaemia.

B. D. de Pauw, J. Raemaekers, P. Koopmans, 1993, European journal of cancer.

Pre-emptive administration of corticosteroids prevents the development of ARDS associated withStreptococcus mitis bacteremia following chemotherapy with high-dose cytarabine

J. Donnelly, J. Raemaekers, B. Pauw, 1994, Annals of Hematology.

Sweet's syndrome as the presenting symptom of hairy cell leukemia with concomitant infection by Mycobacterium kansasii

J. Raemaekers, B. Pauw, A. Horrevorts, 1992, Annals of Hematology.

Involved field irradiation (IFRT) does not improve outcome in patients with stage III/IV Hodgkin's lymphoma (HL) in complete remission after MOPP/ABV (M/A): Results of the randomised EORTC trial 20884

A. Hagenbeek, C. Sebban, U. Tirelli, 2001 .

Patients with stage III/IV Hodgkin's disease in partial remission after MOPP/ABV chemotherapy have excellent prognosis after additional involved-field radiotherapy: interim results from the ongoing EORTC-LCG and GPMC phase III trial. The EORTC Lymphoma Cooperative Group and Groupe Pierre-et-Marie-Cu

J. Raemaekers, A. Hagenbeek, E. Noordijk, 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

Recombinant interferon-alpha, but not interferon-gamma is effective therapie for essential thrombocythemia

C. Haanen, J. Raemaekers, B. Pauw, 2005, Blut.

An open study on the safety and efficacy of fluconazole in the treatment of disseminated Candida infections in patients treated for hematological malignancy

J. Meis, B. Kullberg, J. Donnelly, 1995, Annals of Hematology.

Evolution of the clinical manifestations of infection during the course of febrile neutropenia in patients with malignancy

R. Feld, S. Deresinski, J. Donnelly, 1998, Infection.

Empirical and subsequent use of antibacterial agents in the febrile neutropenic patient

B. D. de Pauw, J. Donnelly, J. Raemaekers, 1997, Journal of internal medicine. Supplement.

Equivalent efficacies of meropenem and ceftazidime as empirical monotherapy of febrile neutropenic patients. The Meropenem Study Group of Leuven, London and Nijmegen.

M. Boogaerts, J. Donnelly, A. Goldstone, 1995, The Journal of antimicrobial chemotherapy.

Empiric treatment of localized infections in the febrile neutropenic patient with monotherapy.

I. Nováková, B. D. de Pauw, J. Donnelly, 1993, Leukemia & lymphoma.

Comparison of CHOP chemotherapy with autologous bone marrow transplantation for slowly responding patients with aggressive non-Hodgkin's lymphoma.

J. Raemaekers, A. Hagenbeek, P. Sonneveld, 1995, The New England journal of medicine.

Long-term efficacy of the CHVmP/BV regimen used for aggressive non-Hodgkin's lymphoma in three randomised EORTC trials.

J. Baars, M. van Glabbeke, E. Noordijk, 2004, European journal of cancer.

Short intensive sequential therapy followed by autologous stem cell transplantation in adult Burkitt, Burkitt-like and lymphoblastic lymphoma

P. Sonneveld, H. Kluin-Nelemans, P. Kluin, 2005, Leukemia.

Prevention of leukemic relapse after transplantation with lymphocyte depleted marrow by intensification of the conditioning regimen with a 6-day continuous infusion of anthracyclines.

A. Schattenberg, J. Raemaekers, N. van der Lely, 1989, Bone marrow transplantation.

Allogeneic bone marrow transplantation for low-grade lymphoma.

J. Armitage, J. Vose, J. Raemaekers, 1998, Blood.

Maintenance of remission with human recombinant interferon alfa-2a in patients with stages III and IV low-grade malignant non-Hodgkin's lymphoma. European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group.

A. Hagenbeek, M. van Glabbeke, M. Glabbeke, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Late relapse in early-stage Hodgkin's disease patients enrolled on European Organization for Research and Treatment of Cancer protocols.

E. Noordijk, J. Bosq, M. Henry-Amar, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Role of allogenic bone marrow transplantation in adolescent or adult patients with acute lymphoblastic leukaemia or lymphoblastic lymphoma in first remission.

C. Haanen, F. Preijers, J. Boezeman, 1994, Bone marrow transplantation.

Recombinant Interferon-α, but not Interferon-γ, is Effective Therapy for Essential Thrombocythemia

C. Haanen, J. Raemaekers, B. Pauw, 1990 .

Richter’s syndrome developing in a patient with adult onset Still’s disease

D. Geurts, K. Hebeda, J. Raemaekers, 2008, Annals of Hematology.

Quantitation of follicular non-Hodgkin's lymphoma cells carrying t(14;18) in a patient before and after allogeneic bone marrow transplantation.

J. Meijerink, T. Smetsers, T. D. de Witte, 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

The tolerability of continuous intravenous infusion of interleukin-3 after DHAP chemotherapy in patients with relapsed malignant lymphoma

W. Fibbe, J. Raemaekers, L. Verdonck, 1993, Annals of Hematology.